Beranda › Neuroblastoma › North Carolina › Durham
Uji klinis Neuroblastoma di Durham, NC
6 studi untuk Neuroblastoma mencari peserta di lokasi sekitar Durham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Menerima pesertaFase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Menerima pesertaFase 2
- Duke University, Durham
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Menerima pesertaFase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Menerima pesertaFase 2
- Duke University, Durham
SPEARHEAD-3 Pediatric Study
Menerima pesertaFase 1/2
- Duke University School of Medicine, Durham
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
Menerima pesertaFase 1
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi jauhnya
Uji klinis Neuroblastoma di kota lain
- Boston, MA13 studi
- Washington, DC11 studi
- New York City, NY10 studi
- Memphis, TN9 studi
- Philadelphia, PA9 studi
- Dallas, TX9 studi
- St. Louis, MO9 studi
- Aurora, CO8 studi
- Hartford, CT8 studi
- Minneapolis, MN8 studi
- Birmingham, AL8 studi
- Atlanta, GA7 studi
Studi lain di Durham
- Kanker Payudara63 studi
- Kanker (semua jenis)58 studi
- Kanker Paru Non-Sel Kecil39 studi
- Mieloma Multipel37 studi
- Kanker Metastatik33 studi
- Leukemia Mieloid Akut33 studi
- Kanker Paru32 studi
- Kanker Prostat32 studi
- Kanker Kolorektal28 studi
- Leukemia Limfositik Kronis27 studi
- Kanker Ovarium27 studi
- Gagal Jantung26 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.